🇺🇸 Anastrozole Tablets in United States

26 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 4 reports (15.38%)
  2. Anxiety — 3 reports (11.54%)
  3. Dizziness — 3 reports (11.54%)
  4. Fatigue — 3 reports (11.54%)
  5. Nausea — 3 reports (11.54%)
  6. Depression — 2 reports (7.69%)
  7. Headache — 2 reports (7.69%)
  8. Insomnia — 2 reports (7.69%)
  9. Malignant Neoplasm Progression — 2 reports (7.69%)
  10. Mood Altered — 2 reports (7.69%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Anastrozole Tablets approved in United States?

Anastrozole Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Anastrozole Tablets in United States?

Tolmar Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.